Cencora, Inc.

NYSE:COR

Medical - Distribution

Healthcare
$348.31 -2.04%

-$5.65 today

Market cap
$66.47B
Beta
0.59
P/E (TTM)
20.7
EPS (TTM)
$13.10
Dividend yield
0.87%
52W Low $244.82High $377.54

Volume 1.20M

Average 1.78M

COR Cash & Equivalents

Cash on hand and highly liquid investments that can be converted to cash almost immediately.

Cencora, Inc.NYSE: COR

Cash & Equivalents · Q3 FY2026 · quarter ended Jun 2026

Cash & equivalents rises 23.7% from a year ago

Cash & equivalents stood at $2.82B at the end of Q3 FY2026, up 23.7% from a year earlier and up 25.9% from the prior quarter. Over 3 fiscal years it compounded at +7.5% a year.

Context

  • Cash & equivalents amounted to 3.4% of total assets at the end of Q3 FY2026, up 0.3 pp from a year earlier.
  • Cash & equivalents increased in 2 of the last 3 fiscal years.
  • FY2025 was the highest annual figure in the 4 fiscal years shown.

What to watch

Whether cash & equivalents keeps rising in the next quarterly balance sheet after a +23.7% change from a year earlier.

Sources:Balance SheetText generated from reported figures; not investment advice.

Latest quarterJun 2026
$2.82B+25.9% QoQ
Last fiscal yearSep 2025
$4.39B+36.0% YoY
Year agoJun 2025
$2.28B+23.7% since
Cash & Equivalents past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+23.7%——
1 year+36.0%——
3-year CAGR+7.5%——
5-year CAGR——
10-year CAGR——

Cash & Equivalents history

USD · from the balance sheet

Latest · FY2025
4.39B USD
Year-over-year change
+36.0%
4-year CAGR
+14.6%

Cash & Equivalents vs competitors

How COR compares with its peers on the latest reported figures

  • COR's Jun 2026 cash & equivalents of $2.82B is the 3rd highest of the 5 companies compared; the peer median is $2.75B.
  • Its year-over-year change of +23.7% is the 3rd highest of 5, against a peer median of +64.1%.
  • Cash & equivalents amounts to 3.4% of total assets for COR, versus a peer median of 7.3%.
COR Competitors Peer median
Cash & Equivalents for COR and competitors
Company Period Latest balance YoY 3-year CAGR% of assets
CAHCardinal Health, Inc.Sep 2026$5.26B +14.6%+6.0%8.8%
MCKMcKesson CorporationJun 2026$5.16B +113.6%-5.3%5.8%
CORCencora, Inc.Jun 2026$2.82B +23.7%+7.5%3.4%
ACHAccendra Health, Inc.Mar 2026$336.88M +466.8%+59.5%13.9%
HSICHenry Schein, Inc.Jun 2026$157M +8.3%+10.1%1.4%
Peer median (excluding COR) $2.75B+64.1%+8.0%7.3%

Competitors are the stored peer set for COR. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Balance Sheet

USD
Metric
FY2021
Sep 2021
FY2022
Sep 2022
FY2023
Sep 2023
FY2024
Sep 2024
FY2025
Sep 2025
Cash & Equivalents2.55B3.53B2.69B3.23B4.39B
Short-term Investments00000
Net Receivables18.39B18.63B20.91B23.87B25.23B
Inventory15.37B17.09B17.45B19B20.49B
Other Current Assets2.13B342.89M1.84B1.71B2.13B
Total Current Assets38.8B39.59B42.8B47.72B52.24B
Property, Plant & Equipment (Net)3.23B3.08B3.15B3.32B4.09B
Goodwill9.03B8.5B9.57B9.32B13.68B
Intangible Assets5.26B4.33B4.43B4B3.77B
Long-term Investments060.37M63.12M66.64M0
Tax Assets290.79M237.57M200.67M246.35M208.81M
Other Non-current Assets726.81M756.32M2.34B2.43B2.6B
Total Non-current Assets18.54B16.97B19.76B19.38B24.35B
Total Assets57.34B56.56B62.56B67.1B76.59B
Account Payables38.01B40.19B45.84B50.94B54.72B
Short-term Debt475.57M1.23B823.81M781.1M371.56M
Tax Payables281.07M281.07M310.68M291.8M337.63M
Deferred Revenue00000
Other Current Liabilities2.87B2.06B2.17B2.55B2.73B
Total Current Liabilities41.36B43.48B48.83B54.28B57.82B
Long-term Debt7.33B5.5B5.07B4.84B8.96B
Deferred Tax Liabilities1.69B1.62B1.66B1.64B1.62B
Deferred Revenue (Non-current)00000
Other Non-current Liabilities5.43B5.03B5.41B4.52B5.03B
Total Non-current Liabilities15.39B13.01B13.06B12.04B17.02B
Total Liabilities56.75B56.49B61.89B66.31B74.84B
Common Stock2.91M2.93M2.95M2.96M2.97M
Retained Earnings1.67B2.98B4.32B5.42B6.53B
Accumulated OCI(445.44M)(1.83B)(1.4B)(989.12M)(901.38M)
Other Stockholders Equity00000
Minority Interest361.06M282.83M144.28M140.8M239.07M
Total Equity584.41M71.27M666.29M786.74M1.75B
Total Debt8.75B7.59B6.82B6.65B10.75B
Net Debt6.2B4.06B4.13B3.42B6.35B

Cencora, Inc.

NYSE:COR

Intrinsic Alpha fair value

Locked

Current Price

$348.31

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.